Novartis Gets DDMAC Letter for Facebook Widget, Brochure

Novartis received two untitled letters in late July 2010 from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC), one on Facebook advertising for its leukemia treatment Tasigna and another on a brochure for hypertension drug Exforge.
The Food & Drug Letter